tiprankstipranks
Advertisement
Advertisement

JP:130A Stock Latest News

Veritas In Silico Reshapes Research Leadership With Executive Officer Change
Company AnnouncementsVeritas In Silico Reshapes Research Leadership With Executive Officer Change
11d ago
130A
Veritas In Silico and SpiroChem Sign Joint Pact on Next-Generation mRNA Drugs
PremiumCompany Announcements
Veritas In Silico and SpiroChem Sign Joint Pact on Next-Generation mRNA Drugs
2M ago
130A
Veritas In Silico Deepens mRNA Drug Partnerships as Loss Widens in Q1 FY2026
PremiumCompany Announcements
Veritas In Silico Deepens mRNA Drug Partnerships as Loss Widens in Q1 FY2026
2M ago
130A
Veritas In Silico Books ¥135 Million Impairment, Keeps 2026 Outlook Intact
PremiumCompany Announcements
Veritas In Silico Books ¥135 Million Impairment, Keeps 2026 Outlook Intact
2M ago
130A
Veritas In Silico Widens Quarterly Losses but Keeps 2026 Outlook Unchanged
PremiumCompany Announcements
Veritas In Silico Widens Quarterly Losses but Keeps 2026 Outlook Unchanged
2M ago
130A
Veritas In Silico Ends mRNA Drug Discovery Collaboration with Takeda
PremiumCompany AnnouncementsVeritas In Silico Ends mRNA Drug Discovery Collaboration with Takeda
3M ago
130A
Veritas In Silico Revamps Board and Audit Lineup Ahead of 10th AGM
Premium
Company Announcements
Veritas In Silico Revamps Board and Audit Lineup Ahead of 10th AGM
5M ago
130A
Veritas In Silico Unveils AI-Driven Strategy to Become Specialty Pharma Leader
Premium
Company Announcements
Veritas In Silico Unveils AI-Driven Strategy to Become Specialty Pharma Leader
5M ago
130A
Veritas In Silico Issues Fiscal 2025 Results With Caution on Forward-Looking Statements
PremiumCompany Announcements
Veritas In Silico Issues Fiscal 2025 Results With Caution on Forward-Looking Statements
5M ago
130A
Veritas In Silico Widens Losses but Targets Revenue Rebound in 2026
PremiumCompany Announcements
Veritas In Silico Widens Losses but Targets Revenue Rebound in 2026
5M ago
130A
Veritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs
PremiumCompany Announcements
Veritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs
6M ago
130A
Veritas In Silico and Jikei University Secure Patent Publication for Novel ALS Nucleic Acid Therapy
PremiumCompany Announcements
Veritas In Silico and Jikei University Secure Patent Publication for Novel ALS Nucleic Acid Therapy
6M ago
130A
Veritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
PremiumCompany AnnouncementsVeritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
7M ago
130A
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
Premium
Company Announcements
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
7M ago
130A
Veritas In Silico Secures Patent for Innovative Drug Delivery System
Premium
Company Announcements
Veritas In Silico Secures Patent for Innovative Drug Delivery System
7M ago
130A
Veritas In Silico Partners with Shimane University for Post-Transplant Drug Development
PremiumCompany Announcements
Veritas In Silico Partners with Shimane University for Post-Transplant Drug Development
8M ago
130A
Veritas In Silico Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Veritas In Silico Inc. Reports Q3 2025 Financial Results
8M ago
130A
Veritas In Silico Inc. Reports Significant Financial Decline
PremiumCompany Announcements
Veritas In Silico Inc. Reports Significant Financial Decline
8M ago
130A
Veritas In Silico Reports Declining Financial Performance for 2025
PremiumCompany Announcements
Veritas In Silico Reports Declining Financial Performance for 2025
8M ago
130A
Veritas In Silico and Dexerials Collaborate on Advanced RNA Measurement Technology
PremiumCompany AnnouncementsVeritas In Silico and Dexerials Collaborate on Advanced RNA Measurement Technology
9M ago
130A
Veritas In Silico Revises FY2025 Financial Forecast Amid Contract Delays
Premium
Company Announcements
Veritas In Silico Revises FY2025 Financial Forecast Amid Contract Delays
9M ago
130A
Veritas In Silico to Relocate Shin-Kawasaki Research Institute
Premium
Company Announcements
Veritas In Silico to Relocate Shin-Kawasaki Research Institute
10M ago
130A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >